EDGAR Filing Documents for 0001477932-15-003063

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001477932-15-003063

Filing Date

2015-05-13

Accepted

2015-05-13 14:22:46

Documents

Period of Report

2015-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	ctxr_10q.htm	10-Q	220476
2	CERTIFICATION	ctxr_ex311.htm	EX-31.1	8344
3	CERTIFICATION	ctxr_ex321.htm	EX-32.1	3041
	Complete submission text file	0001477932-15-003063.txt		1928594

Data Files

Seq	Description	Document	Type	Size
4	XBRL INSTANCE DOCUMENT	ctxr-20150331.xml	EX-101.INS	182883
5	XBRL TAXONOMY EXTENSION SCHEMA	ctxr-20150331.xsd	EX-101.SCH	25110
6	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ctxr-20150331_cal.xml	EX-101.CAL	29443
7	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ctxr-20150331_def.xml	EX-101.DEF	58831
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ctxr-20150331_lab.xml	EX-101.LAB	142269
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ctxr-20150331_pre.xml	EX-101.PRE	117494

Mailing Address 63 GREAT ROAD MAYNARD MA 01754

Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338

Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)